Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups

We describe the results of two vaccinations of a self-experimenting healthy volunteer with SARS-CoV-2-derived peptides performed in March and April 2020, respectively. The first set of peptides contained eight peptides predicted to bind to the individual’s HLA molecules. The second set consisted of...

Descripción completa

Detalles Bibliográficos
Autores principales: Rammensee, Hans-Georg, Gouttefangeas, Cécile, Heidu, Sonja, Klein, Reinhild, Preuß, Beate, Walz, Juliane Sarah, Nelde, Annika, Haen, Sebastian P., Reth, Michael, Yang, Jianying, Tabatabai, Ghazaleh, Bösmüller, Hans, Hoffmann, Helen, Schindler, Michael, Planz, Oliver, Wiesmüller, Karl-Heinz, Löffler, Markus W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146137/
https://www.ncbi.nlm.nih.gov/pubmed/33923363
http://dx.doi.org/10.3390/vaccines9050428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146137/
https://www.ncbi.nlm.nih.gov/pubmed/33923363
http://dx.doi.org/10.3390/vaccines9050428

Ejemplares similares